Report Highlights
The global market for noninvasive cancer diagnostic technologies is expected to grow from $119.9 billion in 2025 and is projected to reach $165.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.6% during the forecast period of 2025 to 2030.
Report Includes
- 71 data tables and 63 additional tables
- In-depth analysis of the global market for noninvasive cancer diagnostics and technologies
- Analyses of the global market trends, with historic revenue (sales data) from 2022 to 2024, 2025 and projections of CAGRs through 2030
- Estimates of the current market size and revenue prospects for the global market, accompanied by a market share analysis by technology, cancer type, end user and region
- Facts and figures pertaining to the global market dynamics, opportunities and deterrents, technological advancements, regulations and prospects, and the impact of macroeconomic factors
- Insights derived from Porter’s Five Forces model, as well as global supply chain analyses
- Review of next-generation novel noninvasive cancer molecular diagnostics platforms, current methods and future perspectives on early-stage cancer detection, and emerging biomarker technologies for diagnosis and treatment of cancer
- Evaluation of the current products, their indications and availability for all the market segments identified, and intended clinical applications
- Patent review, featuring key granted and published patents
- Analysis of the industry structure, including companies’ market shares and rankings, product mappings, strategic initiatives, M&A activity and a venture funding outlook
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
- Profiles of the leading global companies, including F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Koninklijke Philips N.V., Labcorp Holdings Inc., and Abbott
Report Scope
The report provides an overview of noninvasive cancer diagnostics technologies and global markets, with a detailed analysis of current market trends. It presents global revenue ($ Million) for the base year 2024, estimated data for 2025, and forecast data for 2026 through 2030. It also includes detailed insights into revenues, forecasts, product indications, and market segmentation. The market is segmented by cancer type, technologies, and end user. Regional coverage encompasses North America, Europe, the Asia-Pacific, and South Africa, with detailed analyses of the Middle East and Africa (MEA), including major countries such as the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China, and India.
This report provides a detailed overview of noninvasive cancer diagnostic products currently available in the market. It also examines cancer incidence and mortality statistics to provide context for market demand, outlines key challenges limiting the widespread adoption of these technologies, and highlights recent innovations shaping the next generation of diagnostic tools. It provides an in-depth overview of industry dynamics, including opportunities, constraints, and the competitive environment, highlighting both international leaders and smaller regional players active in the market.
The report offers a competitive landscape and includes information on major suppliers and manufacturers, describing their core products and strategic focus areas. It also contains a dedicated section of company profiles that covers details such as overview, key financials, product portfolio, and recent developments in major companies.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2024 | ||||||||||||||||
| Forecast period considered | 2025-2030 | ||||||||||||||||
| Base year market size | $112.8 Billion | ||||||||||||||||
| Market size forecast | $165.2 Billion | ||||||||||||||||
| Growth rate | CAGR of 6.6% for the forecast period of 2025-2030 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | Cancer Type, Technology, End User, and Region | ||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, South America and Middle East and Africa | ||||||||||||||||
| Countries covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, and South Korea | ||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||
| Companies studied |
|
||||||||||||||||
Frequently Asked Questions (FAQs)
- Increasing prevalence of cancer.
- Growing adoption of liquid biopsy technologies.
- Shift toward early and preventive diagnosis.
- Rising healthcare expenditure and R&D funding.
- Shortage of radiologists
- False-positive and false-negative results
- AI-enabled diagnostics and digital pathology
- Emerging markets with underserved screening populations
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Global Markets for Emerging Medical Device Technologies
The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.
Epigenetics: Technologies and Global Markets
The global market for epigenetics research tools and reagents, IVDs and therapeutics is expected to grow from $4.8 billion in 2024 to $8.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.8% from 2024 through 2029.
Artificial Intelligence (AI) in Cancer
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
Next-Generation Cancer Diagnostics: Technologies and Global Markets
The global next-generation cancer diagnostics market reached $8.7 billion in 2022 and should reach $15 billion by 2027, with a compound annual growth rate (CAGR) of 11.5% during the forecast period of 2022-2027.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Noninvasive Cancer Diagnostics: Technologies and Global Markets
The global market for noninvasive cancer diagnostic technologies is expected to grow from $119.9 billion in 2025 and is projected to reach $165.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.6% during the forecast period of 2025 to 2030.
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps and devices is expected to grow from $9.7 billion in 2025 and is projected to reach $14.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.9% during the forecast period of 2025 to 2030.
Technologies for Long-Term Care and Home Healthcare: Global Markets
The global market for technologies for long-term care and home healthcare is estimated to grow from $46.2 billion in 2025 to $64.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7% from 2025 to 2030.
3D Protein Structure Analysis: Global Markets
The global market for 3D protein structure analysis is expected to grow from $3.4 billion in 2025 and is projected to reach $5.3 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2025 to 2030.
Global Sleep Software Market
This report provides detailed information on the global sleep software market. It highlights current and future market trends, as well as a comprehensive competitive landscape. The report analyzes market trends with data from 2024, estimates from 2025, and projections of compound annual growth rates (CAGRs) through 2030.
Top Trending Reports
Stem Cell and Regenerative Therapy: Global Markets
The global market for stem cell and regenerative therapy is projected to grow from an estimated $16.7 billion in 2025 to $43.8 billion by 2030, at a compound annual growth rate (CAGR) of 21.3% from 2025 to 2030.
Cell and Gene Therapy Tools and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is expected to grow from $12 billion in 2025 and is projected to reach $19.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.6% during the forecast period of 2025 to 2030.
State of the Energy & Sustainability Industry - Fourth Quarter Review
State of the Energy & Sustainability Industry Market Report highlights key trends, clean energy growth, sustainability initiatives, and future market outlook worldwide.
Bioprocess Filtration: Global Markets
The global market for bioprocess filtration is estimated to grow from $8.4 billion in 2025 to reach $15.6 billion by 2030, at a compound annual growth rate (CAGR) of 13.1% from 2025 through 2030.
Molecular Diagnostics: Technologies and Global Markets
The global market for molecular diagnostics is expected to grow from $23 billion in 2025 and is projected to reach $42.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2025 to 2030.
Report Highlights
The global market for noninvasive cancer diagnostics was valued at $107.4 billion in 2016. This market is estimated to grow from nearly $114.6 billion in 2017 to $159.8 billion by 2022 with a compound annual growth rate (CAGR) of 6.9% for the period of 2017-2022.
Report Includes
- An overview of the global noninvasive cancer diagnostics market.
- Analyses of global market trends, with data from 2016, estimates for 2017 and projections of compound annual growth rates (CAGRs) through 2022.
- Analysis of the market by principle technology and by geography.
- Detailed breakdown of advanced non-invasive approaches.
- Coverage of segmentation of the cell-free DNA diagnostic methods.
- A look at major factors driving the growth of the non-invasive cancer diagnostic and technologies market.
- Profiles of major players in the industry.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More